Protective effect of chronic caffeine intake on gene expression of brain derived neurotrophic factor signaling and the immunoreactivity of glial fibrillary acidic protein and Ki-67 in Alzheimer's disease

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 7, 2015, Pages 7710-7728

  Ghoneim, Fatma M ^a   Khalaf, Hanaa A ^a   Elsamanoudy, Ayman Z ^a   Abo El khair, Salwa M ^a   Helaly, Ahmed M N ^a   Mahmoud, El Hassanin M ^a   Elshafey, Saad H ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Alzheimer's disease; BNDF signaling; Caffeine; Glial fibrillary acidic protein; Ki 67

Indexed keywords

ALUMINUM CHLORIDE; ALUMINUM DERIVATIVE; BRAIN DERIVED NEUROTROPHIC FACTOR; CAFFEINE; CHLORIDE; GLIAL FIBRILLARY ACIDIC PROTEIN; KI 67 ANTIGEN; PROTEIN TYROSINE KINASE;

ALZHEIMER DISEASE; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HIPPOCAMPUS; HUMAN; MALE; METABOLISM; NERVE CELL; PATHOLOGY; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ALUMINUM COMPOUNDS; ALZHEIMER DISEASE; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CAFFEINE; CHLORIDES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; HUMANS; KI-67 ANTIGEN; MALE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 85012960803     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (87)

1. Kimura R, Ohno M. Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model. Neurobiol Dis 2009; 33: 229-235.
2. Casey G. Alzheimer's and other dementias. Nurs NZ 2012; 18: 20-4.
3. Ansari N, Khodagholi F. Natural products as promising drug candidates for the treatment of Alzheimer's disease: molecular mechanism aspect. Curr Neuropharmacol 2013; 11: 414-29.
4. Kemppainen S, Rantamäki T, Jerónimo-Santos A, Lavasseur G, Autio H, Karpova N, Kärkkäinen E, Stavén S, Vicente Miranda H, Outeiro TF, Diógenes MJ, Laroche S, Davis S, Sebastião AM, Castrén E, Tanila H. Impaired TrkB receptor signaling contributes to memory impairment in APP/PS1 mice. Neurobiol Aging 2011; 33: e23-e39.
5. Han K, Jia N, Li J, Yang L, Min LQ. Chronic caffeine treatment reverses memory impairment and the expression of brain BNDF and TrkB in the PS1/APP double transgenic mouse model of Alzheimer's disease. Mol Med Rep 2013; 8: 737-40.
6. Amin SN, Younan SM, Youssef MF, Rashed LA, Mohamady I. A histological and functional study on hippocampal formation of normal and diabetic rats. F1000Res 2013; 2: 151.
7. Yoo DY, Kim W, Kim DW, Nam SM, Jung HY, Kim JW, Lee CH, Choi JH, Won MH, Yoon YS, Hwang IK. Cell proliferation and neuroblast differentiation in the dentate gyrus of high-fat diet-fed mice are increased after rosiglitazone treatment. J Vet Sci 2014; 15: 27-33.
8. Smith TW, Lippa CF. Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders. J Neuropathol Exp Neurol 1995; 54: 297-303.
9. Santos C, Lunet N, Azevedo A, de Mendonça A, Ritchie K, Barros H. Caffeine intake is associated with a lower risk of cognitive decline: a cohort study from Portugal. J Alzheimers Dis 2010; 20: S175-S185.
10. Arendash GW, Mori T, Cao C, Mamcarz M, Runfeldt M, Dickson A, Rezai-Zadeh K, Tane J, Citron BA, Lin X, Echeverria V, Potter H. Caffeine reverses cognitive impairment and decreases brain amyloid-β levels in aged Alzheimer's disease mice. J Alzheimers Dis 2009; 17: 661-80.
11. Gelber RP, Petrovitch H, Masaki KH, Ross GW, White LR. Coffee intake in midlife and risk of dementia and its neuropathologic correlates. J Alzheimers Dis 2011; 23: 607-15.
12. Karam AM, Nadia AM, Abd El-FH, Nemat AZ, Siham MA, Farrag AH, Bassant MM. Protective Effect of Ginger (Zingiber officinale) on Alzheimer's disease Induced in Rats. J Neuro infect Dis 2014; 5: 159.
13. Shi SS, Shao SH, Yuan BP, Pan F, Li ZL. Acute stress and chronic stress change brain-derived neurotrophic factor (BDNF) and tyrosine kinase-coupled receptor (TrkB) expression in both young and aged rat hippocampus. Yonsei Med J 2010; 51: 661-71.
14. Bancroft JD, Gamble M. "Theory and Practice of Histological Technique" 5th Edition. Churchill Livingstone. Edinburg and London. 2002.
15. Zarnescu O, Brehar FM, Chivu M, Ciurea AV. Immunohistochemical localization of caspase-3, caspase-9 and Bax in U87 glioblastoma xenografts. J Mol Histol 2008; 39: 561-569.
16. Tsukinoki K, Saruta J, Sasaguri K, Miyoshi Y, Jinbu Y, Kusama M, Sato S, Watanabe Y. Immobilization stress induces BDNF in rat submandibular glands. J Dent Res 2006; 85: 844-848.
17. Solum DT, Handa RJ. Estrogen regulates the development of brain-derived neurotrophic factor mRNA and protein in the rat hippocampus. J Neurosci 2002; 22: 2650-9.
18. Tsukinoki K, Saruta J, Muto N, Sasaguri K, Sato S, Tan-Ishii N, Watanabe Y. Submandibular glands contribute to increases in plasma BDNF levels. J Dent Res 2007; 86: 260-264.
19. Newairy AS, Salama AF, Hussien HM, Yousef MI. Propolis alleviates aluminium-induced lipid peroxidation and biochemical parameters in male rats. Food Chem Toxicol 2009; 47: 1093-8.
20. Abbasali KM, Zhila T, Farshad N. Developmen-tal Toxicity of aluminum from High Doses of AlCl3 in Mice. The Journal of Applied Research 2005; 5: 575-579.
21. Deloncle R, Huguet F, Babin P, Fernandez B, Quellard N, Guillard O. Chronic administration of aluminum L-glutamate in young mature rats: effects on iron levels and lipid peroxidation in selected brain areas. Toxicol Lett 1999; 104: 65-73.
22. Pratico D, Uryu K, Sung S, Tang S, Trojanowski JQ, Lee VM. Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice. FASEB J 2002; 16: 1138-1140.
23. Zaky A, Mohammad B, Moftah M, Kandeel KM, Bassiouny AR. Apurinic/apyrimidinic endonuclease 1 is a key modulator of aluminum-induced neuroinflammation. BMC Neurosci 2013; 14: 26.
24. Walton JR. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau and granulovacuolar degeneration. J Inorg Biochem 2007; 101: 1275-1284.
25. Thompson PM, Hayashi KM, De Zubicaray GI, Janke AL, Rose SE, Semple J, Hong MS, Herman DH, Gravano D, Doddrell DM, Toga AW. Mapping hippocampal and ventricular change in Alzheimer disease. Neuroimage 2004; 22: 1754-66.
26. Ihunwo AO, Schliebs R. Cell proliferation and total granule cell number in dentate gyrus of transgenic Tg2576 mouse. Acta Neurobiol Exp (Wars) 2010; 70: 362-9.
27. Padurariu M, Ciobica A, Mavroudis I, Fotiou D, Baloyannis S. Hippocampal neuronal loss in the CA1 and CA3 areas of Alzheimer's disease patients. Psychiatr Danub 2012; 24: 152-8.
28. Nirmala RN, Shankarbhat K, Urban D. Effect of long term administration of aluminum chloride on oxidative stress and acetylcholin-esterase activity in rat brains. IJPBS 2013; 3: 616-622.
29. Yassin NA, El-Shenawy SM, Mahdy KA, Gouda NA, Marrie AE, Farrag AR. Effect of Boswellia serrata on Alzheimer's disease induced in rats. J Arab Soc Med Res 2013; 8: 1-11.
30. Abd El-Rahman SS. Neuropathology of aluminum toxicity in rats (glutamate and GABA impairment). Pharmacol Res 2003; 47: 189-194.
31. Aly HF, Metwally FM, Ahmed HH. Neuro-protective effects of dehydroepiandrosterone (DHEA) in rat model of Alzheimer's disease. Acta Biochim Pol 2011; 58: 513-20.
32. Abo El-Khair DM, El-Safti Fel-N, Nooh HZ, El-Mehi AE. A comparative study on the effect of high cholesterol diet on the hippocampal CA1 area of adult and aged rats. Anat Cell Biol 2014; 47: 117-26.
33. Praticò D, Trojanowski JQ. Inflammatory hypotheses: novel mechanisms of Alzheimer's neurodegeneration and new therapeutic targets? Neurobiol Aging 2000; 21: 441-445.
34. Lynch MA. The impact of neuroimmune changes on development of amyloid pathology; relevance to Alzheimer's disease. Immunology 2014; 141: 292-301.
35. Guillot-Sestier MV, Town T. Innate immunity in Alzheimer's disease: a complex affair. CNS Neurol Disord Drug Targets 2013; 12: 593-607
36. Song J, Zhong C, Bonaguidi MA, Sun GJ, Hsu D, Gu Y, Meletis K, Huang ZJ, Ge S, Enikolopov G, Deisseroth K, Luscher B, Christian KM, Ming GL, Song H. Neuronal circuitry mechanism regulating adult quiescent neural stem-cell fate decision. Nature 2012; 489: 150-4.
37. Nobakht M, Hoseini SM, Mortazavi P, Sohrabi I, Esmailzade B, Rahbar Rooshandel N, Omidzahir S. Neuropathological changes in brain cortex and hippocampus in a rat model of Alzheimer's disease. Iran Biomed J 2011; 15: 51-8.
38. Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 2011; 1: a006189.
39. Ciobica A, Padurariu M, Bild W, Stefanescu C. Cardiovascular risk factors as potential markers for mild cognitive impairment and Alzheimer's disease. Psychiatr Danub 2011; 23: 333-340.
40. Yang HJ, Kwon DY, Kim MJ, Kang S, Moon NR, Daily JW, Park S. Red peppers with moderate and severe pungency prevent the memory deficit and hepatic insulin resistance in diabetic rats with Alzheimer's disease. Nutr Metab (Lond) 2015; 12: 9.
41. Hashem HE, Elmasry SM, Eladl MA. Dentate gyrus in aged male albino rats (histological and Tau-immunohistochemical study). Egypt J Histol 2010; 33: 659-670.
42. Hashish HA. Histopathologic Effect of Prenatal Topiramate Exposure on Rat Cerebral Cortex and Hippocampus. J Interdiscipl Histopathol 2014; 2: 61-68.
43. Lee HU, Yamazaki Y, Tanaka KF, Furuya K, Sokabe M, Hida H, Takao K, Miyakawa T, Fujii S, Ikenaka K. Increased astrocytic ATP release results in enhanced excitability of the hippocampus. Glia 2013; 61: 210-224.
44. Vincent AJ, Gasperini R, Foa L, Small DH. Astrocytes in Alzheimer's disease: emerging roles in calcium dysregulation and synaptic plasticity. J Alzheimers Dis 2010; 22: 699-714.
45. Kraft AW, Hu X, Yoon H, Yan P, Xiao Q, Wang Y, Gil SC, Brown J, Wilhelmsson U, Restivo JL, Cirrito JR, Holtzman DM, Kim J, Pekny M, Lee JM. Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice. FASEB J 2013; 27: 187-98.
46. Kamphuis W, Middeldorp J, Kooijman L, Sluijs JA, Kooi EJ, Moeton M, Freriks M, Mizee MR, Hol EM. Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease. Neurobiol Aging 2014; 35: 492-510.
47. Nielsen HM, Veerhuis R, Holmqvist B, Janciauskiene S. Binding and uptake of a beta1-42 by primary human astrocytes in vitro. Glia 2009; 57: 978-88.
48. Pihlaja R, Koistinaho J, Kauppinen R, Sandholm J, Tanila H, Koistinaho M. Multiple cellular and molecular mechanisms are involved in human Aβ clearance by transplanted adult astrocytes. Glia 2011; 59: 1643-57.
49. Rohn TT, Catlin LW, Poon WW. Caspase-cleaved glial fibrillary acidic protein within cerebellar white matter of the Alzheimer's disease brain. Int J Clin Exp Pathol 2013; 6: 41-8.
50. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000; 182: 311-322.
51. Pascoe MC, Howells DW, Crewther DP, Carey LM, Crewther SG. Fish oil supplementation associated with decreased cellular degeneration and increased cellular proliferation 6 weeks after middle cerebral artery occlusion in the rat. Neuropsychiatr Dis Treat 2015; 11: 153-64.
52. Maruszak A, Pilarski A, Murphy T, Branch N, Thuret S. Hippocampal neurogenesis in Alzheimer's disease: is there a role for dietary modulation? J Alzheimers Dis 2014; 38: 11-38.
53. Yao J, Mu Y, Gage FH. Neural stem cells: mechanisms and modeling. Protein Cell 2012; 3: 251-61.
54. Faigle R, Song H. Signaling mechanisms regulating adult neural stem cells and neurogenesis. Biochim Biophys Acta 2013; 1830: 2435-48.
55. Verret L, Jankowsky JL, Xu GM, Borchelt D, Rampon C. Alzheimer's-type amyloidosis in transgenic mice impairs survival of newborn neurons derived from adult hippocampal neurogenesis. J Neurosci 2007; 27: 6771-80.
56. Mu Y, Gage FH. Adult hippocampal neurogenesis and its role in Alzheimer's disease. Mol Neurodegener 2011; 6: 85.
57. Gomez-Nicola D, Suzzi S, Vargas-Caballero M, Fransen NL, Al-Malki H, Cebrian-Silla A, Garcia-Verdugo JM, Riecken K, Fehse B, Perry VH. Temporal dynamics of hippocampal neurogenesis in chronic neurodegeneration. Brain 2014; 137: 2312-28.
58. Varela-Nallar L, Rojas-Abalos M, Abbott AC, Moya EA, Iturriaga R, Inestrosa NC. Chronic hypoxia induces the activation of the Wnt/β-catenin signaling pathway and stimulates hippocampal neurogenesis in wild-type and APPswe-PS1γE9 transgenic mice in vivo. Front Cell Neurosci 2014; 8: 17.
59. Lazarov O, Marr RA. Neurogenesis and Alzheimer's disease: At the crossroads. Exp Neurol 2010; 223: 267-81.
60. Adachi N, Numakawa T, Richards M, Nakajima S, Kunugi H. New insight in expression, transport, and secretion of brain-derived neurotrophic factor: Implications in brain-related diseases. World J Biol Chem 2014; 5: 409-28.
61. Cheng PL, Song AH, Wong YH, Wang S, Zhang X, Poo MM. Self-amplifying autocrine actions of BDNF in axon development. Proc Natl Acad Sci U S A 2011; 108: 18430-5.
62. Yoshimura T, Kawano Y, Arimura N, Kawabata S, Kikuchi A, Kaibuchi K. GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity. Cell 2005; 120: 137-149.
63. Koo JH, Kwon IS, Kang EB, Lee CK, Lee NH, Kwon MG, Cho IH, Cho JY. Neuroprotective effects of treadmill exercise on BDNF and PI3-K/Akt signaling pathway in the cortex of transgenic mice model of Alzheimer's disease. J Exerc Nutrition Biochem 2013; 17: 151-60.
64. Hock C, Heese K, Hulette C, Rosenberg C, Otten U. Region specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol 2000; 57: 846-851.
65. Chang L, Wang Y, Ji H, Dai D, Xu X, Jiang D, Hong Q, Ye H, Zhang X, Zhou X, Liu Y, Li J, Chen Z, Li Y, Zhou D, Zhuo R, Zhang Y, Yin H, Mao C, Duan S, Wang Q. Elevation of peripheral BDNF promoter methylation links to the risk of Alzheimer's disease. PLoS One 2014; 9: e110773.
66. Chen JH, Ke KF, Lu JH, Qiu YH, Peng YP. Protection of TGF-β1 against neuroinflammation and neurodegeneration in Aβ1-42-induced Alzheimer's disease model rats. PLoS One 2015; 10: e0116549.
67. Lee S, Zemianek J, Shea TB. Rapid, Reversible impairment of synaptic signaling in cultured cortical neurons by exogenously-applied amyloid-β. J Alzheimers Dis 2013; 35: 395-402.
68. Zhao L, Wang JL, Liu R, Li XX, Li JF, Zhang L. Neuroprotective, anti-amyloidogenic and neurotrophic effects of apigenin in an Alzheimer's disease mouse model. Molecules 2013; 18: 9949-65.
69. Poon WW, Blurton-Jones M, Tu CH, Feinberg LM, Chabrier MA, Harris JW, Jeon NL, Cotman CW. β-Amyloid impairs axonal BDNF retrograde trafficking. Neurobiol Aging 2011; 32: 821-33.
70. Baglio F, Saresella M, Preti MG, Cabinio M, Griffanti L, Marventano I, Piancone F, Cala-brese E, Nemni R, Clerici M. Neuroinflammation and brain functional disconnection in Alzhei-mer's disease. Front Aging Neurosci 2013; 5: 81.
71. Arendash GW, Mori T, Cao C, Mamcarz M, Runfeldt M, Dickson A, Rezai-Zadeh K, Tane J, Citron BA, Lin X, Echeverria V, Potter H. Caffeine reverses cognitive impairment and decreases brain amyloid-β levels in aged Alzheimer's disease mice. J Alzheimers Dis 2009; 17: 661-680.
72. Gahr M, Nowak DA, Connemann BJ, Schonfeldt-Lecuona C. Cerebral amyloidal angiopathy-a disease with implications for neurology and psychiatry. Brain Res 2013; 1519: 19-30.
73. Zeitlin R, Patel S, Burgess S, Arendash GW, Echeverria V. Caffeine induces beneficial changes in PKA signaling and JNK and ERK activities in the striatum and cortex of Alzheimer's transgenic mice. Brain Res 2011; 1417: 127-36.
74. Rivera-Oliver M, Díaz-Ríos M. Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review. Life Sci 2014; 101: 1-9.
75. Csoka B, Hasko G. Adenosine, inflammation pathways and therapeutic challenges. Joint Bone Spine 2011; 78: 4-6.
76. Cao C, Wang L, Lin X, Mamcarz M, Zhang C, Bai G, Nong J, Sussman S, Arendash G. Caffeine synergizes with another coffee component to increase plasma GCSF: Linkage to cognitive benefits in Alzheimer's mice. J Alzheimers Dis 2011; 25: 323-35.
77. Cao C, Cirrito JR, Lin X, Wang L, Verges DK, Dickson A, Mamcarz M, Zhang C, Mori T, Arendash GW, Holtzman DM, Potter H. Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice. J Alzheimers Dis 2009; 17: 681-97.
78. Prasanthi JR, Dasari B, Marwarha G, Larson T, Chen X, Geiger JD, Ghribi O. Caffeine protects against oxidative stress and Alzheimer's disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet. Free Radic Biol Med 2010; 49: 1212-20.
79. Chen X, Ghribi O, Geiger JD. Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases. J Alzheimers Dis 2010; 20 Suppl 1: S127-41.
80. Costa MS, Botton PH, Mioranzza S, Souza DO, Porciúncula LO. Caffeine prevents age-associated recognition memory decline and changes brainderived neurotrophic factor and tirosine kinase receptor (TrkB) content in mice. Neuroscience 2008; 153: 1071-8.
81. Sallaberry C, Nunes F, Costa MS, Fioreze GT, Ardais AP, Botton PH, Klaudat B, Forte T, Souza DO, Elisabetsky E, Porciúncula LO. Chronic caffeine prevents changes in inhibitory avoidance memory and hippocampal BDNF immunocontent in middle-aged rats. Neuropharmacology 2013; 64: 153-9.
82. Chen JF, Chern Y. Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies. Handb Exp Pharmacol 2011; 267-310.
83. Mioranzza S, Nunes F, Marques DM, Fioreze GT, Rocha AS, Botton PH, Costa MS, Porciúncula LO. Prenatal caffeine intake differently affects synaptic proteins during fetal brain development. Int J Dev Neurosci 2014; 36: 45-52.
84. Wentz CT, Magavi SS. Caffeine alters proliferation of neuronal precursorsin the adult hippocampus. Neuropharmacology 2009; 56: 994-1000.
85. Chu YF, Chang WH, Black RM, Liu JR, Sompol P, Chen Y, Wei H, Zhao Q, Cheng IH. Crude caffeine reduces memory impairment and amyloid β (1-42) levels in an Alzheimer's mouse model. Food Chem 2012; 135: 2095-102.
86. Eskelinen MH, Kivipelto M. Caffeine as a protective factor in dementia and Alzheimer's disease. J Alzheimers Dis 2010; 20 Suppl 1: S167-74.
87. Panza F, Solfrizzi V, Barulli MR, Bonfiglio C, Guerra V, Osella A, Seripa D, Sabbà C, Pilotto A, Logroscino G. Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review. J Nutr Health Aging 2015; 19: 313-28.